Portfolio
Exited
![](https://ori-capital.com/storage/app/media/new-logo/Semma_Logo.jpg)
Read More
It is the only company applying stem cell therapy to cure type 1 diabetes.
![](https://ori-capital.com/storage/app/media/new-logo/kymab.png)
Read More
World’s first fully humanized antibodies selection platform generating disease-modifying drugs.
Listed
NASDAQ: ORTX
Read More
World’s leading gene therapy company targeting multiple diseases with limited or no existing treatment.
NASDAQ: TLSI
Read More
It is the only company to date that can deliver drugs to pancreatic tumors using its innovative delivery device.
![](https://ori-capital.com/storage/app/media/new-logo/CG_Logo3.jpg)
NASDAQ: CGON
Read More
The leading oncolytic virus company in Phase 3 bladder cancer.
![](https://ori-capital.com/storage/app/media/new-logo/EI_Logo-2019.jpg)
The first ever high-volume biologic injector
![](https://ori-capital.com/storage/app/media/new-logo/Logo.png)
First IVD company in tumor testing space making precision medicine the first-line treatment
![](https://ori-capital.com/storage/app/media/new-logo/AffyimmuneHorz-logo-60px.jpg)
Developing CAR-T therapy focusing on brand new target for solid tumor
![](https://ori-capital.com/storage/app/media/new-logo/Ponce%20de%20Leon.jpg)
Cutting edge anti-aging nutraceutical company